May 17, 2020

The electronic medical records market is estimated to rise to $39.7bn by 2022, report finds

Health technology
Digital health
EHR
USA
Catherine Sturman
2 min
Kalorama Information, a division of MarketResearch.com, has revealed its findings surrounding the rise of electronic medical records in its latest repor...

Kalorama Information, a division of MarketResearch.com, has revealed its findings surrounding the rise of electronic medical records in its latest report, EMR 2018.

Set to rise to $39.7bn by 2022, technology giants Cerner, Epic and Allscripts remain key players in catering to this ongoing demand, where the global market is set to reach $31.5bn this year alone.

From 2018-2022, the market is expected to grow at a compound average rate of 6% per year, according to a recent release.

As healthcare providers and organisations continue to adopt fragmented health technologies with minimal room for collaboration, data sharing remains increasingly complex, placing additional strains on providing patient centered care, with increased silos across various systems.

This is only exacerbated further if a patient moves from public to private healthcare, with no system on the market providing complete interoperability.

See also

With this in mind, growth within the market has become boosted by conversions of remaining hospital systems to automated, digital tools and systems, as well as upgrades of existing customers, new services and vendor switches. Vendors are continuing to look at ways to further provide advanced information to gain a more detailed picture of a patient’s health.

Whilst hospitals and health technology providers work to automate clinical processes to drive efficiencies and boost relationships into ambulatory physician-based practices, smaller health providers have limited resources to invest in its digital infrastructure, EMR systems included.

Consequently, Epic, Cerner, Allscripts, athenahealth and MEDITECH have been found to be working to close this gap and provider further support, leading this segment to become one of the fastest growing areas in the EHR market, according to recent KLAS Research report.

However, Practice Management System (PMS) companies have remained keen to adopt new technologies and bring on board a mixture of EMR/PMS combinations, creating seamless clinical system strategies, as well as ensuring effective vendor-customer relationships. Cerner, Allscripts and Epic are also leading this area.

 

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article